COCP
Cocrystal Pharma, Inc.
Latest Form 4:Purchase$10KbyFROST PHILLIP MD ET AL (Director, 10% Owner) · filed Aug 6, 2026
Cocrystal Pharma, Inc. (COCP) has 7 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 6, 2026.
The most active filer is Director, 10% Owner FROST PHILLIP MD ET AL with 8 filings. Insiders have net bought $148K over the trailing 6 months.
- Industry:Biotechnology
- CEO:James E. Sapirstein
- Employees:10
- HQ:Bothell, WA, US
- IPO:2012-02-22
Insider Buying
$277K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$15.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 10,000 | $10K | Aug 6 | SEC ↗ | |
FROST PHILLIP MD ET ALFirst in 5 months | Director, 10% Owner | Purchase | 75,000 | $71K | Aug 5 | SEC ↗ |
| Director, 10% Owner | Purchase | 20,000 | $20K | Feb 25 | SEC ↗ | |
| Director, 10% Owner | Purchase | 50,000 | $47K | Feb 9 | SEC ↗ | |
| Director, 10% Owner | Purchase | 50,000 | $47K | Jan 2 | SEC ↗ | |
| Director, 10% Owner | Purchase | 20,000 | $19K | Dec 31 | SEC ↗ | |
FROST PHILLIP MD ET ALFirst filing | Director, 10% Owner | Purchase | 25,000 | $24K | Dec 29 | SEC ↗ |
FROST PHILLIP MD ET ALFirst filing | Director, 10% Owner | Purchase | 40,000 | $39K | Dec 29 | SEC ↗ |
Related companies
Cocrystal Pharma, Inc. is in the Healthcare sector.